This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rice, A P Articles by Carlotti, F Search for Related Content PubMed PubMed Citation Articles by Rice, A P Articles by Carlotti, F

Structural analysis of wild-type and mutant human immunodeficiency virus type 1 Tat proteins.

Cold Spring Harbor Laboratory, New York 11724.

ABSTRACT

We expressed the human immunodeficiency virus type 1 transactivator protein, Tat, in the wheat germ cell-free translation system and found it to exist as a monomer. The first coding exon (residues 1 to 72) of wheat germ-expressed Tat was resistant to trypsin digestion, indicating that it is a highly folded, independently structured protein domain. Several mutant Tat proteins were dramatically more sensitive to trypsin than the wild type was, suggesting that their reduced transactivation activities are the result of destabilized structures. Mutant proteins with single-amino-acid substitutions were also identified that had reduced transactivation activities but wild-type structures in the trypsin assay. These mutants clustered in two regions of Tat, at acidic residues 2 and 5 in the amino terminus and between residues 18 and 32. These mutants, wild type in structure but reduced in activity, identify residues in the wild-type protein that may directly contact other molecules during Tat function.

This article has been cited by other articles:

• Ruckwardt, T. J., Tikhonov, I., Berg, S., Hatfield, G. S., Chandra, A., Chandra, P., Gilliam, B., Redfield, R. R., Gallo, R. C., Pauza, C. D. (2004). Sequence Variation within the Dominant Amino Terminus Epitope Affects Antibody Binding and Neutralization of Human Immunodeficiency Virus Type 1 Tat Protein. J. Virol. 78: 13190-13196 [Abstract] [Full Text]  
• Beriault, V., Clement, J.-F., Levesque, K., LeBel, C., Yong, X., Chabot, B., Cohen, E. A., Cochrane, A. W., Rigby, W. F. C., Mouland, A. J. (2004). A Late Role for the Association of hnRNP A2 with the HIV-1 hnRNP A2 Response Elements in Genomic RNA, Gag, and Vpr Localization. J. Biol. Chem. 279: 44141-44153 [Abstract] [Full Text]  
• Liu, Y., Li, J., Kim, B. O., Pace, B. S., He, J. J. (2002). HIV-1 Tat Protein-mediated Transactivation of the HIV-1 Long Terminal Repeat Promoter Is Potentiated by a Novel Nuclear Tat-interacting Protein of 110 kDa, Tip110. J. Biol. Chem. 277: 23854-23863 [Abstract] [Full Text]  
• Cota-Gomez, A., Flores, N. C., Cruz, C., Casullo, A., Aw, T. Y., Ichikawa, H., Schaack, J., Scheinman, R., Flores, S. C. (2002). The Human Immunodeficiency Virus-1 Tat Protein Activates Human Umbilical Vein Endothelial Cell E-selectin Expression via an NF-kappa B-dependent Mechanism. J. Biol. Chem. 277: 14390-14399 [Abstract] [Full Text]  
• Pendergrast, P. S., Wang, C., Hernandez, N., Huang, S. (2002). FBI-1 Can Stimulate HIV-1 Tat Activity and Is Targeted to a Novel Subnuclear Domain that Includes the Tat-P-TEFb---containing Nuclear Speckles. Mol. Biol. Cell 13: 915-929 [Abstract] [Full Text]  
• O'Keeffe, B., Fong, Y., Chen, D., Zhou, S., Zhou, Q. (2000). Requirement for a Kinase-specific Chaperone Pathway in the Production of a Cdk9/Cyclin T1 Heterodimer Responsible for P-TEFb-mediated Tat Stimulation of HIV-1 Transcription. J. Biol. Chem. 275: 279-287 [Abstract] [Full Text]  
• Mitola, S., Soldi, R., Zanon, I., Barra, L., Gutierrez, M. I., Berkhout, B., Giacca, M., Bussolino, F. (2000). Identification of Specific Molecular Structures of Human Immunodeficiency Virus Type 1 Tat Relevant for Its Biological Effects on Vascular Endothelial Cells. J. Virol. 74: 344-353 [Abstract] [Full Text]  
• Jeang, K.-T., Xiao, H., Rich, E. A. (1999). Multifaceted Activities of the HIV-1 Transactivator of Transcription, Tat. J. Biol. Chem. 274: 28837-28840 [Full Text]  
• Ramanathan, Y., Reza, S. M., Young, T. M., Mathews, M. B., Pe'ery, T. (1999). Human and Rodent Transcription Elongation Factor P-TEFb: Interactions with Human Immunodeficiency Virus Type 1 Tat and Carboxy-Terminal Domain Substrate. J. Virol. 73: 5448-5458 [Abstract] [Full Text]  
• Chen, D., Zhou, Q. (1999). Tat Activates Human Immunodeficiency Virus Type 1 Transcriptional Elongation Independent of TFIIH Kinase. Mol. Cell. Biol. 19: 2863-2871 [Abstract] [Full Text]  
• Chen, D., Fong, Y., Zhou, Q. (1999). Specific interaction of Tat with the human but not rodent P-TEFb complex mediates the species-specific Tat activation of HIV-1 transcription. Proc. Natl. Acad. Sci. USA 96: 2728-2733 [Abstract] [Full Text]  
• Zhu, Y., Pe'ery, T., Peng, J., Ramanathan, Y., Marshall, N., Marshall, T., Amendt, B., Mathews, M. B., Price, D. H. (1997). Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro. Genes Dev. 11: 2622-2632 [Abstract] [Full Text]  
• Willbold, D, Rosin-Arbesfeld, R, Sticht, H, Frank, R, Rosch, P (1994). Structure of the equine infectious anemia virus Tat protein. Science 264: 1584-1587 [Abstract]